Our top pick for
Beginners

Misonix Inc is a medical devices business based in the US. Misonix shares (MSON) are listed on the NASDAQ and all prices are listed in US Dollars. Misonix employs 281 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | $20.69 - $26.99 |
---|---|
50-day moving average | $25.62 |
200-day moving average | $22.03 |
Wall St. target price | $28.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.84 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $N/A from 2021-11-16
1 week (2022-06-19) | N/A |
---|---|
1 month (2022-05-26) | N/A |
3 months (2022-03-26) | N/A |
6 months (2021-12-26) | N/A |
1 year (2021-06-30) | -100.00% |
---|---|
2 years (2020-06-30) | -100.00% |
3 years (2019-06-28) | -100.00% |
5 years (2017-06-30) | -100.00% |
Revenue TTM | $74 million |
---|---|
Gross profit TTM | $52.6 million |
Return on assets TTM | -2.87% |
Return on equity TTM | -10.27% |
Profit margin | -19.55% |
Book value | $7.77 |
Market capitalisation | $462.5 million |
TTM: trailing 12 months
We're not expecting Misonix to pay a dividend over the next 12 months.
Misonix's shares were split on a 3:2 basis on 20 October 1997. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Misonix shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Misonix shares which in turn could have impacted Misonix's share price.
Over the last 12 months, Misonix's shares have ranged in value from as little as $20.69 up to $26.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Misonix's is 1.3513. This would suggest that Misonix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Misonix, Inc. , together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator, which is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.